ポイント・オブ・ケア検査の世界市場：グルコース監視キット、心血管代謝監視キット、感染症検査キット、凝集モニタリングキット、腫瘍マーカー...市場調査レポートについてご紹介

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation Methodology
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Research Design
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 32)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 37)
4.1 Market Overview
4.2 Geographic Analysis: Market Growth Rate, By Product (2016–2021)
4.3 Geographic Analysis: Market Size, By Mode of Prescription, 2016 vs 2021
4.4 Market, By End User and Region, 2016 (USD Million)

5 Market Overview (Page No. – 41)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence of Infectious Diseases in Developing Countries
5.3.1.2 Increasing Incidence of Lifestyle Diseases
5.3.1.3 Rising Usage of Home-Based POC Devices
5.3.1.4 Growing Government Support
5.3.1.5 Private Investments and Venture Capital Activities
5.3.1.6 Technological Advancements and New Product Launches
5.3.1.7 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
5.3.1.8 Shortage of Skilled Laboratory Technicians Increasing Preference of POC Testing
5.3.1.9 Rising Number of Clia-Waived POC Tests
5.3.2 Restraints
5.3.2.1 Product Recalls
5.3.2.2 Pricing Pressures Owing to Reimbursement Cuts and Budget Constraints Hampering Profits
5.3.2.3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches
5.3.3 Opportunities
5.3.3.1 Emerging Markets (India, China, and Brazil) to Pave New Growth Avenues
5.3.3.2 Healthcare Decentralization—Converting Lab Tests to POC Tests
5.3.3.3 Increasing Number of Conferences and Events
5.3.3.4 Miniaturization of POC Testing Devices
5.3.3.5 POC Tests With Multiplexing Capabilities
5.3.4 Challenges
5.3.4.1 Lack of Alignment With Definitive Central Lab Methods
5.3.4.2 Disadvantages of POC Testing Over Central Lab Methods
5.3.4.3 Inadequate Knowledge About Use of POC Devices in Professional Settings
5.3.4.4 Reluctance Towards Changing Existing Treatment Practices
5.3.5 Burning Issues
5.3.5.1 Unfavorable Reimbursement Limiting the Adoption of POC Tests
5.3.5.2 High Cost of Devices—A Prime Concern
5.3.5.3 Negative Public Perception Related to POC Tests

6 Industry Trends (Page No. – 58)
6.1 Introduction
6.2 Industry Trends
6.2.1 Standardization of POC Testing Devices
6.2.2 Acquisition of Small Players
6.2.3 Growing Focus on Microfluidics-Based POC Devices
6.2.3.1 Microfluidics-Based Loc Devices Will Bring Laboratory Testing to the Patient’s Fingertips
6.2.3.2 Evolution of Paper-Based Microfluidic POC Diagnostic Devices
6.3 Pricing and Cost Analysis
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry
6.5 Strategic Benchmarking
6.5.1 Technology Integration & New Product Launches
6.5.2 Incorporation of Wireless Technology in POC Devices

7 Point-Of-Care Diagnostics Market, By Product (Page No. – 68)
7.1 Introduction
7.2 Glucose Monitoring Kits
7.3 Cardiometabolic Monitoring Kits
7.3.1 Cardiac Markers
7.3.2 Blood Gas/Electrolytes Testing Kits
7.3.3 HBA1C Testing Kits
7.3.4 LIPID Testing Kits
7.4 Infectious Disease Testing Kits
7.4.1 Influenza Testing Kits
7.4.2 HIV Testing Kits
7.4.3 Hepatitis C Testing Kits
7.4.4 Sexually Transmitted Diseases (STDs) Testing Kits
7.4.5 Tropical Diseases Testing Kits
7.4.6 Healthcare-Associated Infection Testing Kits
7.4.7 Respiratory Infections Testing Kits
7.4.8 Other Infectious Disease Testing Kits
7.5 Coagulation Monitoring Kits
7.5.1 PT/INR Testing Kits
7.5.2 Activated Clotting Time (ACT/APTT) Testing Kits
7.6 Pregnancy and Fertility Testing Kits
7.6.1 Pregnancy Testing Kits
7.6.2 Fertility Testing Kits
7.7 Tumor/Cancer Markers
7.8 Urinalysis Testing Kits
7.9 Cholesterol Test Strips
7.10 Hematology Testing Kits
7.11 Drugs-Of-Abuse Testing Kits
7.12 Fecal Occult Testing Kits
7.13 Other POC Testing Kits

8 Point-Of-Care Diagnostics Market, By Prescription Mode (Page No. – 109)
8.1 Introduction
8.2 Prescription-Based Testing Kits
8.3 OTC Testing Kits Market

9 Point-Of-Care Diagnostics Market, By End User (Page No. – 115)
9.1 Introduction
9.2 Professional Diagnostic Centers
9.2.1 Hospitals/Critical Care Settings
9.2.2 Outpatient Healthcare Settings
9.2.3 Ambulatory Care Settings
9.3 Research Laboratories
9.4 Home Care
9.5 Others

10 Point-Of-Care Diagnostics Market, By Region (Page No. – 124)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Growing Prevalence of Lifestyle Diseases and Rising Geriatric Population
10.2.1.2 Increasing Government and Venture Capital Funding
10.2.1.3 Growing Number of Product Approvals Using Clia Waiver
10.2.1.4 Nih Support for the Development of POC Testing Devices
10.2.1.5 Slow Inflow of Multi-Analyte POC Devices
10.2.2 Canada
10.2.2.1 Expanding Patient Population Base
10.2.2.2 Increasing Focus of Players on the Canadian Market
10.2.2.3 Increasing Government Initiatives
10.2.2.4 Lack of Reimbursement and Awareness
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Number of Conferences
10.3.1.2 Ongoing Development of Novel Products
10.3.1.3 Rising Incidence of Diabetes and Cancer in Germany
10.3.1.4 Low Reimbursement Affecting Market Growth in the Country
10.3.2 France
10.3.2.1 Increasing Reimbursement for Point-Of-Care Tests
10.3.2.2 High Prevalence of Diabetes in France
10.3.3 U.K.
10.3.3.1 Growing Number of New Product Launches
10.3.3.2 Increasing Government Support for POCt Devices
10.3.3.3 Budget Constraints Hampering Market Growth
10.3.4 Rest of Europe (RoE)
10.4 Asia-Pacific
10.4.1 Japan
10.4.1.1 Growing Initiatives By Market Players
10.4.1.2 Increasing Demand for Rapid Flu Tests in Japan
10.4.1.3 Centralized Healthcare Delivery System
10.4.2 China
10.4.2.1 Increasing Partnerships and Joint Ventures Fueling Market Growth
10.4.2.2 Increasing Support From Government and Private Companies
10.4.2.3 Poor Reimbursement and Time-Consuming Product Registration Procedure
10.4.3 India
10.4.3.1 Increasing Prevalence of Target Diseases
10.4.3.2 Growing Government Initiatives
10.4.3.3 Conferences
10.4.3.4 Lack of Reimbursement and Insurance Coverage Hampering Market Growth
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World (RoW)
10.5.1 Increasing Patient Population in Africa
10.5.2 Huge Patient Base for Respiratory Diseases
10.5.3 Growing Initiatives By Market Players

11 Competitive Landscape (Page No. – 168)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches,Product Enhancements, and Product Approvals
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Product Showcase and Product Recall
11.3.4 Acquisitions
11.3.5 Other Strategies

12 Company Profiles (Page No. – 175)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.3 Abbott Laboratories, Inc.
12.4 Siemens AG
12.5 Alere Inc.
12.6 Johnson & Johnson
12.7 Instrumentation Laboratory (A Werfen Company)
12.8 Nova Biomedical
12.9 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
12.10 Becton, Dickinson and Company
12.11 PTs Diagnostics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 207)
13.1 Discussion Guide
13.2 Other Developments
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports